BFIM
AMED

Beese Fulmer Investment Management’s Amedisys AMED Stock Holding History

Beese Fulmer Investment Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-100
Closed -$20K – 211
2020
Q2 		$20K Buy
+100
New +$18.7K ﹤0.01% 407

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Beese Fulmer Investment Management's AMED Position: Q3 2020 in Review

Beese Fulmer Investment Management sold out of Amedisys (AMED) in Q3 2020, closing a stake of 100 shares — an estimated $20K sold.

Beese Fulmer Investment Management first reported a position in AMED in Q2 2020 and held it in 1 quarter. The position peaked at $20K in Q2 2020. 397 funds tracked by Wall St. Rank hold AMED as of Q3 2020.

  • Beese Fulmer Investment Management reported no remaining Amedisys position as of Q3 2020 after selling out during the quarter.
  • Beese Fulmer Investment Management sold 100 Amedisys shares in Q3 2020, an estimated $20K.
  • Beese Fulmer Investment Management first reported a position in Amedisys in Q2 2020 and held it in 1 quarter.
  • Beese Fulmer Investment Management's Amedisys position peaked at $20K in Q2 2020.
  • 397 funds tracked by Wall St. Rank held Amedisys as of Q3 2020.

Based on Beese Fulmer Investment Management's 13F filing for Q3 2020, filed 8 Oct 2020.